Chief Investigators

EJS ACT-PD is being led by MRC CTU at UCL with the Chief Investigators from University College London (UCL) and Newcastle University (NU). 

Tom Foltynie

Professor Tom Foltynie is Professor of Neurology at University College London and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery.

He has a specialist interest in Parkinson’s disease (PD), Deep Brain stimulation and the development of novel treatments for PD.

Prof. Foltynie is involved in several trials of new treatments for PD, including chief investigator for a series of trials of Exenatide- a potential neurorestorative treatment for PD. He is excited to be continuing his work in exploring disease modifying treatments for PD through EJS ACT-PD.

Camille Carroll

Professor Camille Carroll is Professor of Clinical Neuroscience at Newcastle University and University of Plymouth and Honorary Consultant Neurologist at University Hospitals Plymouth.

Dr Carroll is UK Lead for Neurodegenerative Diseases for the National Institute of Health and Care Research Clinical Research Network (NIHR CRN) and  Co-clinical Director of the Parkinson’s Excellence Network at Parkinson’s UK.

She has successfully led PD STAT, a nation-wide trial of simvastatin, the largest neuroprotective trial in the UK, and is leading the development of a web-based research register (JPR) for Parkinson’s.

Dr Carroll is looking forward to realising the vision of developing a multi-arm, multi-stage platform trial for Parkinson’s.